Sales of foreign-invested pharmaceutical firms up 14.6%

The combined sales of the 22 major foreign drug makers last year marked a growth rate of 14.6 percent, to 3.2 trillion won from 2006, according to data analyzed by Yakup Shinmoon. Their operating income showed an average increase of 6.8 percent.

By sales, Pfizer Korea topped the list with 396.7 billion won, followed by Aventis Pharma with 373.4 billion won and GlaxoSmithKline with 356.3 bill...